The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Meropenem 1 g powder for solution for injection or infusion

Acino AGPA2168/002/002

Main Information

Trade NameMeropenem 1 g powder for solution for injection or infusion
Active SubstancesMeropenem Trihydrate
Dosage FormPowder for solution for injection/infusion
Licence HolderAcino AG
Licence NumberPA2168/002/002

Group Information

ATC CodeJ01DH Carbapenems
J01DH02 meropenem


License statusAuthorised
Licence Issued24/02/2012
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back